JUN and neoplasm: In acquired immune resistance, TIL-secreted IFN-γ and tumor antigen-specific T-cells mediate PD-L1 upregulation after tumor antigen recognition, and this functions as a tumor escape mechanism that uses constitutive oncogenic signaling, such as c-Jun and STAT3.